Vibrant Therapeutics is a clinical-stage biotechnology company developing intelligent, logic-gated therapeutics designed to selectively activate in the disease microenvironment.
The company leverages an integrated computational and experimental ("dry-wet") R&D platform to advance a pipeline of masked T-cell engagers and other prodrug therapies targeting solid tumors, including its lead program VIB305 for EGFR-positive cancers.
Leadership & Board
Current Number of Employees10
Current LinkedIn Followers753
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$61M
Total Amount Raised$61M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$61M
Latest Funding Amount$61M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Vibrant Therapeutics had 10 employees as of October 5, 2026. The number of employees increased by 0 (0.00%) week-over-week.
10Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Vibrant Therapeutics had 753 followers as of October 5, 2026. The number of followers increased by 3 (0.40%) week-over-week.
753Latest Followers Count
3(0.40%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.